Sintx Technologies (SINT) is now covered by HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Sintx Technologies (SINT) had its price target lowered by Ascendiant Capital Markets from $16.00 to $12.00. They now have a "buy" rating on the stock.
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution [Yahoo! Finance]
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms